Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 42M | 80M | 80M | 64M | 94M | 76M |
| Cost of revenue | 31M | 50M | 39M | 41M | 60M | 53M |
| Gross profit | 11M | 30M | 18M | 23M | 34M | 23M |
| Research and development | 5M | 4M | 4M | 4M | 4M | 5M |
| Selling, general and administrative | 9M | 8M | 7M | 8M | 6M | 7M |
| Operating expenses | 25M | 25M | 19M | 22M | 28M | 27M |
| Operating income | −14M | 5M | −329,000 | 2M | 6M | −4M |
| Pre-tax income | −15M | 2M | −3M | −773,000 | 3M | −7M |
| Income tax | −123,000 | 254,000 | −246,000 | −109,000 | 46,000 | 841,000 |
| Net income | −15M | 2M | −3M | −664,000 | 3M | −8M |
| Earnings per share | −0.78 | 0.09 | −0.14 | −0.03 | 0.17 | −0.35 |
| Earnings per share, diluted | −0.78 | 0.08 | −0.14 | −0.03 | 0.16 | −0.35 |
| Weighted average shares | 19M | 20M | 21M | 21M | 21M | 21M |
| Weighted average shares, diluted | 19M | 20M | 21M | 21M | 22M | 21M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 12M | 17M | 12M | 12M | 12M | 13M | 14M | 12M |
| Receivables | 30M | 77M | 57M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 29M | — | — | 40M | — | — |
| Depreciation and amortisation | 892,000 | 1M | 1M | 1M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 36M |
| 42M |
| 93M |
| 71M |
| 46M |
| Inventory | 64M | 69M | 95M | 77M | 74M | 71M | 102M | 73M |
| Current assets | 118M | 174M | 178M | 138M | 142M | 188M | 196M | 144M |
| Property, plant and equipment | 2M | 3M | 4M | 5M | 5M | 6M | 6M | 6M |
| Goodwill | 50M | 50M | 50M | 50M | 50M | 53M | 57M | 57M |
| Total assets | 210M | 269M | 278M | 240M | 247M | 299M | 313M | 264M |
| Current liabilities | 48M | 88M | 112M | 75M | 72M | 124M | 156M | 103M |
| Short-term debt | 9M | 9M | 9M | — | — | 1M | — | — |
| Long-term debt | 44M | 46M | 48M | 40M | 46M | 46M | 46M | 46M |
| Total liabilities | 98M | 141M | 168M | 123M | 126M | 178M | 211M | 159M |
| Equity | 112M | 128M | 111M | 117M | 121M | 121M | 102M | 105M |
| Shares outstanding | 20M | 19M | 19M | 20M | 20M | 20M | 20M | 21M |
| Shares issued | 20M | 19M | 19M | 20M | 20M | 20M | 20M | 21M |
| 1M |
| 1M |
| Capital expenditure | 276,000 | — | — | 166,000 | — | — |
| Investing cash flow | −276,000 | — | — | 2M | — | — |
| Share buybacks | 2M | — | — | 2M | — | — |
| Financing cash flow | −34M | — | — | −45M | — | — |